Scouting report · CAI

Luke Power

Joined Caris in 2011 as an accounting manager; CFO since February 2023

Born / age
(44)
Role
SVP, Chief Financial Officer & Chief Accounting Officer
In the role
4 yr
Education
Degree Waterford Institute of Technology
Front Office rank
not ranked yet
CAI
Caris Life Sciences, Inc.Diagnostics
Title
SVP, Chief Financial Officer & Chief Accounting Officersrc
In role
since 2023-02 (4 yr)
Stake value—no holding or price on file
—thin record

Scouting sheetas of 24 Sep 2026

Delivers guidance—no promises on the record yet
Answers the question—no call reviewed yet
Capital allocation—company not reviewed yet
Pay design—no proxy read yet
Skin in the game—no holding or price on file
—Hit rate
—Pay at risk
—Say-on-pay
—Airtime on calls
Beat
0
Met
0
Missed
0
Withdrawn
0
Still open
0
Answers on calls
0
Questions dodged
0
Dodges / 100 answers
—

Personal and ownership data

Full name
Luke Power
Age
44src
Education
Degree Finance and accounting, Waterford Institute of Technologysrc

Not on file yet: born, place of birth, citizenship, marital status.

Shares held
153,771 CAI, 2026-05-15src
Share of company
0.05%
Traded, 12 months
bought $0, sold $1.7msrc

What to weigh

Red flag 1

  • Disclosure controls were not effective at 2026-06-30. A material weakness (too few qualified accounting staff for complex transactions), found in the FY2024 audit, is still being remediated, and he is both CFO and CAOsrc

Watch 3

  • An earlier material weakness (several control deficiencies in applying GAAP) was reported for FY2022-FY2023 while he was CAO. EY then declined to stand for the 2024 audit, and Deloitte was engaged in September 2024src
  • His pay is not disclosed. He was not a named executive officer in the 2026 proxy or the IPO prospectus, and as an emerging growth company Caris reports only three NEOssrc
  • On 2025-12-11 he exercised 62,250 options at $2.44 and sold 62,250 shares for about $1.65m under a 10b5-1 plan adopted 2025-08-19. Afterwards he held 99,571 shares, which were the 250 shares on his IPO Form 3 plus the 99,321 IPO RSUssrc

Career

  1. 2023-02 – now
    Caris Life Sciencessrc
    SVP, Chief Financial Officer & Chief Accounting Officer
    CFO through the April 2025 crossover financing and the June 2025 IPO
  2. 2017-04 – 2023-02
    Caris Life Sciencessrc
    Chief Accounting Officer
  3. 2016-05 – 2016-09
    Caris Life Sciencessrc
    Senior Director of Accounting
  4. 2013-08 – 2016-05
    Caris Life Sciencessrc
    Director of Accounting
  5. 2011-12 – 2013-08
    Caris Life Sciencessrc
    Financial Reporting and Accounting Manager
    Joining role; the filing does not give its end date, which is taken as the start of the next role
  6. 2002-11 – 2011-10
    PricewaterhouseCooperssrc
    Manager, international assurance practice
    The Caris bio adds that he worked in PwC's assurance practice in Ireland, the United States and the United Kingdom (WS-bio)

Not located: 2016-09 to 2017-04: the 10-K and the IPO prospectus give him no title between Senior Director of Accounting and Chief Accounting Officer

The promise ledger

No promise on the record yet: the research routine has not scored this company's guidance.

Background

  • Family The 2026 proxy names only one family relationship among directors and executive officers, the Halbert brothers. None involves himsrc
  • Other Caris native: every job in the ten-year window is at Caris. He has no public-company CFO role elsewheresrc
  • Other Named with the CEO and General Counsel as a proxy holder for the 2026 annual meeting, and signed the meeting's 8-Ksrc

Sources9